Apolipoprotein AI from Human Plasma Low Endotoxin Level

<strong>Apolipoprotein AI from Human Plasma Low Endotoxin Level</strong>_x000D_ <strong>Catalog number:</strong> B2014984_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 500 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 28000_x000D_ <strong>Supplied as:</strong> Frozen_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80°C_x000D_ <strong>Keywords:</strong> Apolipoprotein AI, Human Plasma, Low Endotoxin Level_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Jin X, Xu Q, Champion K, Kruth HS. Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation--a cautionary tale Atherosclerosis. 2015 May;240(1):121-4._x000D_ 2: Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In vivo protection against endotoxin by plasma high density lipoprotein Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12040-4._x000D_ 3: Tsai MH, Peng YS, Chen YC, Lien JM, Tian YC, Fang JT, Weng HH, Chen PC, Yang CW, Wu CS. Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis J Hepatol. 2009 May;50(5):906-15._x000D_ 4: Kim MH, de Beer MC, Wroblewski JM, Webb NR, de Beer FC. SAA does not induce cytokine production in physiological conditions Cytokine. 2013 Feb;61(2):506-12._x000D_ 5: Levels JH, Geurts P, Karlsson H, Marée R, Ljunggren S, Fornander L, Wehenkel L, Lindahl M, Stroes ES, Kuivenhoven JA, Meijers JC. High-density lipoprotein proteome dynamics in human endotoxemia Proteome Sci. 2011 Jun 28;9(1):34._x000D_ 6: Levels JH, Lemaire LC, van den Ende AE, van Deventer SJ, van Lanschot JJ. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure Crit Care Med. 2003 Jun;31(6):1647-53._x000D_ 7: Kitchens RL, Thompson PA. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins J Endotoxin Res. 2003;9(2):113-8._x000D_ 8: Ting HJ, Stice JP, Schaff UY, Hui DY, Rutledge JC, Knowlton AA, Passerini AG, Simon SI. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha Circ Res. 2007 Feb 16;100(3):381-90._x000D_ 9: Thompson PA, Berbée JF, Rensen PC, Kitchens RL. Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein Innate Immun. 2008 Dec;14(6):365-74._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/17980169">10: Levels JH, Pajkrt D, Schultz M, Hoek FJ, van Tol A, Meijers JC, van Deventer SJ. Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis Biochim Biophys Acta. 2007 Dec;1771(12):1429-38. </a>_x000D_ _x000D_ <strong>Products Related to Apolipoprotein AI from Human Plasma Low Endotoxin Level can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>